Selectins and IL-6 during the clinical course of idiopathic thrombocytopenic purpura

Acta Haematologica

Volumn 101, Issue 1, 1999, Pages 16-20

  Haznedaroǧlu, Ibrahim C ^a,b   Büyükaşik, Yahya ^a   Koşar, Ali ^a   Özcebe, Osman I ^a   Kirazli, Şerafettin ^a   Dündar, Semra ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

E selectin; Idiopathic thrombocytopenic purpura; Interleukin 6; L selectin; Megakaryocytopoiesis; P selectin

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 6; L SELECTIN; PADGEM PROTEIN; SELECTIN; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOLOGY; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; RELAPSE; SPLENECTOMY; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT;

EID: 0345003765     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000040915     Document Type: Article

References (56)

1. Karpatkin S: Autoimmune thrombocytopenic purpura. Blood 1980;56:329-343.
2. McMillan R: Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1981;304:1135-1147.
3. Doan CA, Bouroncle BA, Wiseman BK: Idiopathic and secondary thrombocytopenic purpura: Clinical study and evaluation of 381 cases over a period of 28 years. Ann Intern Med 1960;53:861-867.
4. Kelton JG, Gibbon S: Autoimmune platelet destruction: Idiopathic thrombocytopenic purpura. Semin Thromb Hemost 1982;8:83-104.
5. Schattner E, Bussel J: Mortality in immune thrombocytopenic purpura: Report of seven cases and consideration of prognostic indicators. Am J Hematol 1994;46:120-126.
6. Burstein SA, Peng J, Friese P, Wolf RF, Harrison P, Downs T, Hamilton K, Comp P, Dale GL: Cytokine-induced alteration of platelet and hemostatic function. Stem Cells 1996; 14(suppl 1):154-162.
7. Hirsh J, Glynn MF, Mustard JF: The effect of platelet age on platelet adherence to collagen. J Clin Invest 1968;47:466-473.
8. Karpatkin S: Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. J Clin Invest 1969;48:1083-1087.
9. Harker LA, Slichter SJ: The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 1972;287:155-159.
10. Zucker-Franklin D: Megakaryocyte and platelet structure in thrombopoiesis: The effect of cytokines. Stem Cells 1996;14(suppl 1):1-17.
11. Zucker-Franklin D: Platelet structure and function; in Kuter DJ, Hunt P, Sheridan W, Zucker-Franklin D (eds): Thrombopoiesis and Thrombopoietins. Molecular, Cellular, Preclinical, and Clinical Biology. Totowa, Humana Press, 1997, pp 41-62.
12. Tavassoli M: Stress platelets in normal individuals and patients with idiopathic thrombocytopenic purpura. Commentary: Stress platelet: A platelet equivalent of stress reticulocyte. Blood Cells 1992;18:295-300.
13. Peng JP, Friese P, Heilmann E, George JN, Burstein SA, Dale GL: Aged platelets have an impaired response to thrombin as quantitated by P-selectin expression. Blood 1994;83:161-166.
14. Kansas GS: Selectins and their ligands: Current concepts and controversies. Blood 1996;88: 3259-3287.
15. Parmentier S, McGregor L, Catimel B, Leung LLK, McGregor JL: Inhibition of platelet functions by a monoclonal antibody (LYP20) directed against a granule membrane glycoprotein (GMP-140/PADGEM). Blood 1991;77: 1734-1739.
16. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B: Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992;359:848-851.
17. 2+-dependent adhesion of activated platelets to many different types of leukocytes: Detection by flow cytometry. Blood 1992;80:134-142.
18. Boukerche H, Ruchaud-Sparagano MH, Rouen C, Brochier J, Kaplan C, McGregor JL: A monoclonal antibody directed against a granule membrane glycoprotein (GMP-140/PADGEM, P-selectin, CD62P) inhibits ristocetin-induced platelet aggregation. Br J Haematol 1996;92:442-451.
19. Berman CL, Yeo EL, Wencel-Drake JD, Furie BC, Ginsberg MH, Furie B: A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. J Clin Invest 1986;78:130-137.
20. Isenberg WM, McEver RP, Shuman MA, Bainton DF: Topographic distribution of a granule membrane protein (GMP-140) that is expressed on the platelet surface after activation: An immunogold-surface replica study. Blood Cells 1986;12:191-203.
21. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF: GMP-140, a platelet α-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 1989;84:92-99.
22. Kostelijk EH, Fijnheer R, Nieuwenhuis HK, Gouwerok CWN, de Korte D: Soluble P-selectin as parameter for platelet activation during storage. Thromb Haemost 1996;76: 1086-1089.
23. Blann AD, Lip GYH, Beevers DG, McCollum CN: Soluble P-selectin in atherosclerosis: A comparison with endothelial cell and platelet markers. Thromb Haemost 1997;77:1077-1080.
24. Blann AD, Lip GYH: Hypothesis: Is soluble P-selectin a new marker of platelet activation? Atherosclerosis 1997;128:135-138.
25. Newman W, Beall LD, Carson CW, Hunder GG, Graben N, Randhawa ZI, Gopal TV, Wiener-Kronish J, Matthay MA: Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 1993; 150:644-654.
26. Kneidinger R, Bahrami S, Redl H, Schlag G, Robinson M: Comparison of endothelial activation during endotoxic and posttraumatic conditions by serum analysis of soluble E-selectin in nonhuman primates. J Lab Clin Med 1996;128:515-519.
27. Williams N, Bertoncello I, Jackson H, Kavnoudias H: The role of interleukin 6 in megakaryocyte formation, megakaryocyte development and platelet production. Ciba Found Symp 1992;167:160-170.
28. Zucker-Franklin D: Effect of cytokines on the development of megakaryocytes and platelets. An ultrastruclural analysis; in Kuter DJ, Hunt P, Sheridan W, Zucker-Franklin D (eds): Thrombopoiesis and Thrombopoietins. Molecular, Cellular, Preclinical, and Clinical Biology. Totowa, Humana Press, 1997, pp 237-255.
29. Navarro S, Debili N, Le Couedic JP, Klein B, Breton-Gorius J, Doly J, Vainchenker W: Interleukin-6 and its receptor are expressed by human megakaryocyte: In vitro effects on proliferation and endoreduplication. Blood 1991; 77:461-471.
30. Haznedaroǧlu İC, Ertenli İ, Özcebe Oİ, Kiraz S. Özdemir O, Sayinalp NM, Dündar SV, Çalguneri M, Kirazli Ş: Megakaryocyte-related interleukins in reactive thrombocytosis versus autonomous thrombocytemia. Acta Haematol 1996;95:107-111.
31. Koike K, Nakahata T, Kubo T, Kikuchi T, Takagi M, Ishiguro A, Tsuji K, Naganuma K, Okano A, Akiyama Y, Akabane T: Interleukin-6 enhances murine megakaryocytopoiesis in serum-free culture. Blood 1990;75:2286-2291.
32. Kimura H, Ishibashi T, Ushida T, Maruyama Y, Friese P, Burstein SA: Interleukin-6 is differentiation factor for human megakaryocytes in vitro. Eur J Immunol 1990;20:1927-1931.
33. Hill RJ, Warren MK, Stenberg P, Levin J, Corash L, Drummond R, Baker G, Levin F, Mok Y: Stimulation of megakaryocytopoiesis in mice by human recombinant interleukin-6. Blood 1991;77:42-48.
34. Imai T, Koike K, Kubo T, Kikuchi T, Amano Y, Takagi M, Okumura N, Nakahata T: Inter-leukin-6 supports human megakaryocyte proliferation and differentiation in vitro. Blood 1991;78:1969-1974.
35. Leven RM, Rodriguez A: Immunomagnetic bead isolation of megakaryocytes from guinea-pig bone marrow: Effect of recombinant interleukin-6 on size, ploidy and cytoplasmic fragmantation. Br J Haematol 1991;77:267-273.
36. Peng J, Friese P, George JN, Dale GL, Burstein SA: Alteration of platelet function in dogs mediated by interleukin-6. Blood 1994;83:398-403.
37. Peng J, Friese P, Wolf RP, Harrison P, Downs T, Lok S, Dale GL, Burnstein SA: Relative reactivity of platelets from thrombopoietin and interleukin-6-treated dogs. Blood 1996;87: 4158-4169.
38. Oleksowicz L, Mrowiec Z, Zuckerman D, Isaacs R, Dutcher J, Puszkin E: Platelet activation induced by interleukin-6: Evidence for a mechanism involving arachidonic acid metabolism. Thromb Haemost 1994;72:302-308.
39. Kuter DJ: The physiology of platelet production. Stem Cells 1996;14(suppl 1):88-101.
40. Wang ZY, Shen ZX: Megakaryocytes and platelets in immune thrombocytopenic purpura. Baillières Clin Haematol 1997;10:89-107.
41. Wada H, Minamikawa K, Ohiwa M, Kaneko T, Mori Y, Tamaki S, Takagi M, Kageyama S, Katayama N, Minami N, et al: Elevated plasma interleukin-6 in patients with idiopathic thrombocytopenic purpura. Rinsho Ketsueki 1991;32:773-776.
42. Ballem PJ, Segal GM, Stratton JR, Gernsheimer T, Adamson JW, Slichter SJ: Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearence. J Clin Invest 1987;80:33-40.
43. 51Cr-labeled platelets differ. Blood 1986;67:86-92.
44. Stahl CP, Zucker-Franklin D, Evatt BL, Winton EF: Effects of human interleukin-6 on megakaryocyte development and thrombopoiesis in primates. Blood 1991;78:1467-1475.
45. Aarden LA, van Kooten C: The action of interleukin 6 on lymphoid populations. Ciba Found Symp 1992;167:68-74.
46. Baumann H, Marinkovic-Pajovic S, Won KA, Jones VE, Campos SP, Jahreis P, Morella KK: The action of interleukin 6 and leukaemia inhibitory factor on liver cells. Ciba Found Symp 1992;167:100-114.
47. Akira S, Kishimoto T: Role of interleukin-6 in macrophage function. Curr Opin Hematol 1996;3:87-93.
48. Schleiffenbaum B, Spertini O, Tedder TF: Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol 1992;119:229-238.
49. Griffin JD, Spertini O, Ernst TJ, Belvin MP, Levine HB, Kanakura Y, Tedder TF: GM-CSF and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocyte, and their precursors. J Immunol 1990;145:576-584.
50. Luscinskas FW, Gimbrone MA: Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. Annu Rev Med 1996;47:413-421.
51. Zetterberg E, Richter J: Correlation between serum level of soluble L-selectin and leukocyte count in chronic myeloid and lymphocytic leukemia and during bone marrow transplantation. Eur J Haematol 1993;51:113-119.
52. Nomura S, Yanabu M, Miyake T, Miyazaki Y, Kido H, Kagawa H, Fukuhara S, Komiyama Y, Matsuura E, Koike T: Relationship of microparticles with beta 2-glycoprotein 1 and P-selectin positivity to anticardiolipin antibodies in immune thrombocytopenic purpura. Ann Hematol 1995;70:25-30.
53. Jy W, Horstman LL, Arce M, Ahn YS: Clinical significance of platelet mircoparticles in autoimmune thrombocytopenias. J Lab Clin Med 1992;119:334-345.
54. Galli M, Grassi A, Barbui T: Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Thromb Haemost 1996;75:427-431.
55. Horstman LL, Jy W, Schultz DR, Mao WW, Ahn YS: Complement-mediated fragmentation and lysis of opsonized platelets: Gender differences in sensitivity. J Lab Clin Med 1994;123: 515-525.
56. Zucker-Franklin D, Karpatkin S: Res cell and platelet fragmentation in idiopathic thrombocytopenic purpura. N Engl J Med 1977;297: 517-523.